Allspring Global Investments’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
VCM
VPM
EIG
Allspring Global Investments's DGX Position: Q1 2026 in Review
Allspring Global Investments increased its Quest Diagnostics (DGX) stake by 2% in Q1 2026, buying an estimated $64.7K and bringing the position to 16,645 shares worth $3.29M. The position accounts for 0.01% of the portfolio, ranked #949.
Allspring Global Investments first reported a position in DGX in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.13M in Q2 2023. 1,066 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Allspring Global Investments held 16,645 shares of Quest Diagnostics worth $3.29M as of Q1 2026.
- Allspring Global Investments bought 333 Quest Diagnostics shares in Q1 2026, an estimated $64.7K.
- Quest Diagnostics made up 0.01% of Allspring Global Investments's portfolio in Q1 2026, its #949 holding.
- Allspring Global Investments first reported a position in Quest Diagnostics in Q4 2021 and has held it in 18 quarters since.
- Allspring Global Investments's Quest Diagnostics position peaked at $4.13M in Q2 2023.
- 1,066 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.